A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity.

ABSTRACT:

SUBMITTER: Burgoyne AM 

PROVIDER: S-EPMC7385619 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature